How the battle against Covid became a forever war
Many predicted the virus would become a mild illness akin to a common cold. But as the Omicron variant spreads, scientists say there may be worse…
By
Anjana Ahuja is a science journalist and contributing writer for the Financial Times.
Many predicted the virus would become a mild illness akin to a common cold. But as the Omicron variant spreads, scientists say there may be worse…
By Anjana AhujaEven if an effective vaccine does emerge, its value as a tool for reopening economies will trigger squabbles over…
By Anjana AhujaThe government uses “number theatre” to distract from the lack of clear guidance.
By Anjana AhujaCracking down hard on online misinformation and disinformation is equivalent to vaccination.
By Anjana AhujaGenetics does not recognise race as a biologically meaningful concept, but that doesn’t stop racists invoking its findings.
By Anjana AhujaGlobal population boom may now be turning to population bust. The consequences, for better or worse, will shape our…
By Anjana AhujaRemarkably, Martin Rees’s extended menu of our potential fates does not feel as depressing as it ought to.
By Anjana Ahuja